Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

1993 • 5,539 citations

Paclitaxel (Taxol)

1995 • 1,747 citations

Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer

2008 • 899 citations

Anthracycline-Induced Cardiotoxicity

1996 • 754 citations

Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies

2008 • 611 citations

Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study

2006 • 593 citations

Randomized Phase III Study of Docetaxel Compared With Paclitaxel in Metastatic Breast Cancer

2005 • 533 citations

How Accurate Is Clinician Reporting of Chemotherapy Adverse Effects? A Comparison With Patient-Reported Symptoms From the Quality-of-Life Questionnaire C30

2004 • 531 citations

Peripheral Neuropathy Induced by Microtubule-Stabilizing Agents

2006 • 462 citations

DIFFERENCES IN UROLOGIST AND PATIENT ASSESSMENTS OF HEALTH RELATED QUALITY OF LIFE IN MEN WITH PROSTATE CANCER: RESULTS OF THE CAPSURE DATABASE

1998 • 407 citations

Diagnosis, Management, and Evaluation of Chemotherapy-Induced Peripheral Neuropathy

2006 • 391 citations

Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy

2003 • 320 citations

Failure of Higher-Dose Paclitaxel to Improve Outcome in Patients With Metastatic Breast Cancer: Cancer and Leukemia Group B Trial 9342

2004 • 271 citations

Peripheral nerve damage associated with administration of taxanes in patients with cancer

2008 • 234 citations

Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy

1998 • 203 citations

Validation and reduction of FACT/GOG-Ntx subscale for platinum/paclitaxel-induced neurologic symptoms: a gynecologic oncology group study

2007 • 192 citations

Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02

2009 • 190 citations

Taxanes for adjuvant treatment of early breast cancer

2007 • 189 citations

Grading of chemotherapy-induced peripheral neuropathy

2000 • 163 citations

Phase III Trial Comparing Three Doses of Docetaxel for Second-Line Treatment of Advanced Breast Cancer

2006 • 155 citations

Assessing health-related quality of life in palliative care: Comparing patient and physician assessments

2006 • 125 citations

Cross-cultural validation of an international questionnaire, the General Measure of the Functional Assessment of Cancer Therapy scale (FACT-G), for Japanese.

2001 • 102 citations

Integrating Patient-Reported Outcomes Into Cancer Symptom Management Clinical Trials Supported by the National Cancer Institute–Sponsored Clinical Trials Networks

2007 • 100 citations

Chemotherapy-induced peripheral neuropathy.

1997 • 78 citations

Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study)

2008 • 53 citations

A Questionnaire Survey of Physicians' Perspectives Regarding the Assessment of Chemotherapy-induced Peripheral Neuropathy in Patients with Breast Cancer

2008 • 38 citations

Techniques for the neurological examination of taxane-induced neuropathy

2004 • 8 citations

Deleted Work

1955 • 0 citations